title: Canine cognitive dysfunction as a model for human age-related cognitive decline, dementia and Alzheimer's disease: clinical presentation, cognitive testing, pathology and response to 1-deprenyl therapy.
authors.affiliation: Deprenyl Animal Health, Inc., Overland Park, KS 66210, USA.
authors.forename: W W
authors.initials: WW
authors.lastname: Ruehl
authors.forename: D S
authors.initials: DS
authors.lastname: Bruyette
authors.forename: A
authors.initials: A
authors.lastname: DePaoli
authors.forename: C W
authors.initials: CW
authors.lastname: Cotman
authors.forename: E
authors.initials: E
authors.lastname: Head
authors.forename: N W
authors.initials: NW
authors.lastname: Milgram
authors.forename: B J
authors.initials: BJ
authors.lastname: Cummings
mesh_terms: D000375:Aging / Q000502:physiology; D000544:Alzheimer Disease / Q000188:drug therapy / Q000503:physiopathology*; D000818:Animals; D003072:Cognition Disorders / Q000188:drug therapy / Q000503:physiopathology*; D003704:Dementia / Q000188:drug therapy / Q000503:physiopathology; D004195:Disease Models, Animal; D004285:Dogs; D006801:Humans; D012642:Selegiline / Q000627:therapeutic use*
chemical_list: D012642:Selegiline